Skip to main content
European Health and Digital Executive Agency (HaDEA)
Artykuł prasowy18 maj 2021

Notice to manufacturers and authorised representatives on the impact of genetic variants on SARS-COV-2 in vitro diagnostic medical devices

Notice to manufacturers and authorised representatives on the impact of genetic variants on SARS-COV-2 in vitro diagnostic medical devices

Informacje szczegółowe

Data publikacji
18 maj 2021
Programme Sector
Health
Tags
COVID-19Medical research